Back

Oral anticoagulation monotherapy versus dual antithrombotic therapy in chronic coronary syndrome patients requiring long-term anticoagulation: a bayesian meta-analysis of randomised controlled trials

29 August 2026 (11:15 - 11:45)
Organised by: Logo
Congress Presentation Part of: Managing and improving safety in antithrombotic pharmacotherapy Anticoagulants ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Brandon Yair Rodriguez-Tapia

Antenor Orrego Private University - UPAO, Trujillo (Peru)

2 More presentations in this session

Presentation thumbnail
Development and validation of a novel bleeding risk score during direct oral anticoagulant therapy in patients with cancer-associated venous thromboembolism
Doctor T. Nagai (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Intraoperative antithrombotic drug removal during urgent CABG: early German experience with a novel hemoadsorption device
Professor U. Zeymer (Ludwigshafen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Managing and improving safety in antithrombotic pharmacotherapy

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention: a systematic review and individual patient data network meta-analysis.
30 August 2026
thumbnail
Congress Presentation
Single vs. dual antithrombotic therapy in patients with stabilized coronary artery disease requiring long-term oral anticoagulation: A Bayesian meta-analysis
30 August 2026
thumbnail
Congress Presentation
Short-term DAPT followed by P2Y12 monotherapy versus standard-term DAPT after PCI for ACS: an updated systematic review and meta-analysis of randomised controlled trials
30 August 2026
thumbnail
Congress Presentation
Vericiguat and cardiovascular outcomes in heart failure revisited: a bayesian reanalysis of 12,877 patients
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources